BACKGROUND: Optimal care for patients with diabetes is difficult to achieve in clinical practice. OBJECTIVE: To evaluate the impact of a registry and decision support system on processes of care, and physiologic control. PARTICIPANTS: Randomized trial with clustering at the practice level, involving 7,412 adults with diabetes in 64 primary care practices in the Northeast. INTERVENTIONS: Provider decision support (reminders for overdue diabetes tests, alerts regarding abnormal results, and quarterly population reports with peer comparisons) and patient decision support (reminders and alerts). MEASUREMENTS AND MAIN RESULTS: Process and physiologic outcomes were evaluated in all subjects. Functional status was evaluated in a random patient sample via questionnaire. We used multiple logistic regression to quantify the effect, adjusting for clustering and potential confounders. Intervention subjects were significantly more likely to receive guideline-appropriate testing for cholesterol (OR = 1.39; [95%CI 1.07, 1.80] P = 0.012), creatinine (OR = 1.40; [95%CI 1.06, 1.84] P = 0.018), and proteinuria (OR = 1.74; [95%CI 1.13, 1.69] P = 0.012), but not A1C (OR = 1.17; [95% CI 0.80, 1.72] P = 0.43). Rates of control of A1C and LDL cholesterol were similar in the two groups. There were no differences in blood pressure, body mass index, or functional status. CONCLUSIONS: A chronic disease registry and decision support system based on easily obtainable laboratory data was feasible and acceptable to patients and providers. This system improved the process of laboratory monitoring in primary care, but not physiologic control.
RCT Entities:
BACKGROUND: Optimal care for patients with diabetes is difficult to achieve in clinical practice. OBJECTIVE: To evaluate the impact of a registry and decision support system on processes of care, and physiologic control. PARTICIPANTS: Randomized trial with clustering at the practice level, involving 7,412 adults with diabetes in 64 primary care practices in the Northeast. INTERVENTIONS: Provider decision support (reminders for overdue diabetes tests, alerts regarding abnormal results, and quarterly population reports with peer comparisons) and patient decision support (reminders and alerts). MEASUREMENTS AND MAIN RESULTS: Process and physiologic outcomes were evaluated in all subjects. Functional status was evaluated in a random patient sample via questionnaire. We used multiple logistic regression to quantify the effect, adjusting for clustering and potential confounders. Intervention subjects were significantly more likely to receive guideline-appropriate testing for cholesterol (OR = 1.39; [95%CI 1.07, 1.80] P = 0.012), creatinine (OR = 1.40; [95%CI 1.06, 1.84] P = 0.018), and proteinuria (OR = 1.74; [95%CI 1.13, 1.69] P = 0.012), but not A1C (OR = 1.17; [95% CI 0.80, 1.72] P = 0.43). Rates of control of A1C and LDL cholesterol were similar in the two groups. There were no differences in blood pressure, body mass index, or functional status. CONCLUSIONS: A chronic disease registry and decision support system based on easily obtainable laboratory data was feasible and acceptable to patients and providers. This system improved the process of laboratory monitoring in primary care, but not physiologic control.
Authors: T D Koepsell; E H Wagner; A C Cheadle; D L Patrick; D C Martin; P H Diehr; E B Perrin; A R Kristal; C H Allan-Andrilla; L J Dey Journal: Annu Rev Public Health Date: 1992 Impact factor: 21.981
Authors: Marjorie L Pearson; Shinyi Wu; Judith Schaefer; Amy E Bonomi; Stephen M Shortell; Peter J Mendel; Jill A Marsteller; Thomas A Louis; Mayde Rosen; Emmett B Keeler Journal: Health Serv Res Date: 2005-08 Impact factor: 3.402
Authors: Russell E Glasgow; Paul A Nutting; Diane K King; Candace C Nelson; Gary Cutter; Bridget Gaglio; Alanna Kulchak Rahm; Holly Whitesides Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: Patrick J O'Connor; Jay Desai; Leif I Solberg; Laurel A Reger; A Lauren Crain; Stephen E Asche; Teresa L Pearson; Cynthia K Clark; William A Rush; Linda M Cherney; Joann M Sperl-Hillen; Donald B Bishop Journal: Diabetes Care Date: 2005-08 Impact factor: 19.112
Authors: Charles D MacLean; Benjamin Littenberg; Michael Gagnon; Mimi Reardon; Paul D Turner; Cy Jordan Journal: Clin Trials Date: 2004 Impact factor: 2.486
Authors: Thomas D Sequist; Tejal K Gandhi; Andrew S Karson; Julie M Fiskio; Donald Bugbee; Michael Sperling; E Francis Cook; E John Orav; David G Fairchild; David W Bates Journal: J Am Med Inform Assoc Date: 2005-03-31 Impact factor: 4.497
Authors: Lorenzo Moja; Koren H Kwag; Theodore Lytras; Lorenzo Bertizzolo; Linn Brandt; Valentina Pecoraro; Giulio Rigon; Alberto Vaona; Francesca Ruggiero; Massimo Mangia; Alfonso Iorio; Ilkka Kunnamo; Stefanos Bonovas Journal: Am J Public Health Date: 2014-10-16 Impact factor: 9.308
Authors: Gibril J Njie; Krista K Proia; Anilkrishna B Thota; Ramona K C Finnie; David P Hopkins; Starr M Banks; David B Callahan; Nicolaas P Pronk; Kimberly J Rask; Daniel T Lackland; Thomas E Kottke Journal: Am J Prev Med Date: 2015-11 Impact factor: 5.043
Authors: Gbenga Ogedegbe; Jonathan N Tobin; Senaida Fernandez; Andrea Cassells; Marleny Diaz-Gloster; Chamanara Khalida; Thomas Pickering; Joseph E Schwartz Journal: Circulation Date: 2014-03-21 Impact factor: 29.690
Authors: Lawrence S Phillips; Diana Barb; Chun Yong; Anne M Tomolo; Sandra L Jackson; Darin E Olson; Mary K Rhee; Ingrid M Duva; Qing He; Qi Long Journal: J Diabetes Sci Technol Date: 2015-03-09